Xiangxue Pharmaceutical Co.,Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, diet sarsae, juice soda, soymilk, coconut juice, and fruit enzyme; and antiviral oral liquids under the Xiangxue brand name. It also provides medical devices, which includes disposable stereoscopic fixation system for brain; medical orthopedic and cosmetic adhesives; medical tumor serosa sealing adhesives; medical anastomotic adhesives; medical aural and encephalic adhesives; medical obturation adhesives; medical adhesives; and endoscopic trocar. The company was founded in 1986 and is based in Guangzhou, China.
Frequently asked questions
What sector does Xiangxue Pharmaceutical (300147) operate in?
Xiangxue Pharmaceutical belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Xiangxue Pharmaceutical (300147) current stock price?
As of the latest data, Xiangxue Pharmaceutical stock price is CN¥7.45, with a previous close of CN¥7.39. Xiangxue Pharmaceutical gained CN¥0.06 in the last trading session, representing a 0.81% increase.
What is Xiangxue Pharmaceutical (300147) current market capitalization?
Xiangxue Pharmaceutical market cap is approximately 4.93 billion.
What is Xiangxue Pharmaceutical (300147) Earnings Per Share (EPS)?
The trailing EPS is -CN¥2.08.
Does Xiangxue Pharmaceutical (300147) pay dividends?
No. Xiangxue Pharmaceutical does not pay a dividend.
What is Xiangxue Pharmaceutical (300147) beta (volatility) score?
Xiangxue Pharmaceutical has a beta of 0.562, indicating lower volatility than the overall market.
